Holen Sie sich die Stockscreener-App
3.726
23.76%
0.696
Schlusskurs vom Vortag:
$3.03
Offen:
$3.66
24-Stunden-Volumen:
39,266
Relative Volume:
3.33
Marktkapitalisierung:
$N/A
Einnahmen:
$18.10M
Nettoeinkommen (Verlust:
$-16.56M
KGV:
-3.8971
EPS:
-0.9561
Netto-Cashflow:
$-7.45M
1W Leistung:
+51.52%
1M Leistung:
+441.13%
6M Leistung:
+179.85%
1J Leistung:
+179.85%
1-Tages-Spanne:
$3.61
$3.93
1-Wochen-Bereich:
$3.03
$3.93
52-Wochen-Spanne:
$0.2564
$3.93
Marpai Inc Stock (MRAI) Company Profile
Compare MRAI vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRAI
Marpai Inc
|
3.726 | 0 | 18.10M | -16.56M | -7.45M | -0.9561 |
UNH
Unitedhealth Group Inc
|
391.59 | 359.79B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
95.44 | 122.87B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
398.19 | 87.17B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
276.50 | 72.89B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
400.01 | 48.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
Marpai Inc Aktie (MRAI) Neueste Nachrichten
Marpai Inc (NASDAQ: MRAI) Share Price, MRAI Stock News, MRAI Share Price & Updates - Kalkine
Enterprise value to revenue forward of Marpai, Inc. – OTC:MRAI - TradingView
Marpai Inc (MRAI) Key Financial Ratios – Valuation, Profitability & More - Value Research
Marpai Inc (MRAI) Peer Comparison – Compare with Others - Value Research
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - 01net
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView
Marpai, Inc. Expands Relationship with Claritev Corporation to Help Reduce Healthcare Costs for Employer Clients - marketscreener.com
Marpai Q2 revenue down 10.5% to USD 4.2M - Medical Buyer
Marpai Q2 loss per share narrows to $(0.18) as revenue falls 10.5% - scanx.trade
Marpai Q2 revenue falls due to turnover and continued customer pruning - TradingView
Marpai Reports Second Quarter 2026 Financial Results - PR Newswire
Marpai, Inc. (MRAI) flags going-concern risk amid heavy debt and losses - Stock Titan
Marpai (MRAI) investor group discloses 10.1% stake and board observer rights - Stock Titan
Calvin Steven Mitchell Discloses Investment at Marpai, Inc. with 9.3% Stake - TradingView
Marpai, Inc. (MRAI) gains 9.3% shareholder as Mitchell and Benchmark file 13D - Stock Titan
Marpai, Inc. (MRAI) insider details warrants and 3M-share preferred conversion - Stock Titan
Marpai, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Marpai cuts costs, improves margins, and streng... - Pluang
Enterprise value to EBITDA forward of Marpai, Inc. – OTC:MRAI - TradingView
Marpai Raises $12.1 Million in Series A Preferred Private Placement Led by Mitchell Companies - TradingView
Marpai Establishes New Preferred Stock to Support Growth - TipRanks
Marpai lands $12.1M private placement led by Mitchell Companies - Dealroom
Marpai raises $12 million in private placement By Investing.com - Investing.com Nigeria
Marpai raises $12 million in private placement - Investing.com
Price to sales forward of Marpai, Inc. – OTC:MRAI - TradingView
Marpai Highlights Major Debt Restructuring to Boost Flexibility - The Globe and Mail
Marpai Restructures AXA Maestro Purchase Payments; Defers 35% Proceeds Until $5M Raised - TradingView
Marpai Restructures Debt, Cuts Near-Term Debt Service by $26.4 Million - citybiz
Marpai Extends Debt Maturities to April 2028 and Dec. 2029 - Stock Titan
Dallas Scrip Net Worth (2026) - GuruFocus
Marpai CFO Steve Johnson buys $682 in stock, granted award By Investing.com - Investing.com India
[Form 4] Marpai, Inc. Insider Trading Activity - Stock Titan
Marpai CFO Steve Johnson buys $682 in stock, granted award - Investing.com
Marpai (MRAI) director receives 175,000-share grant and forfeits 50,000 RSUs - Stock Titan
Marpai (MRAI) director reports 125,000-share RSU grant and 50,000 RSU forfeiture - Stock Titan
Marpai (MRAI) director reports 100K RSU grant and 484K shares - Stock Titan
Marpai (MRAI) director gets 100,000-share RSU grant, forfeits 50,000 - Stock Titan
Marpai (MRAI) director DiClaudio receives 125,000-share fully vested stock grant - Stock Titan
Marpai secures 192,000 new member lives, projects profitability - Investing.com
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 - PR Newswire
Marpai to add 192,000 new members, aiming positive cash flow and EBITDA by Aug 2026 - Pluang
Marpai (MRAI) director Eitan Yaron adds 10,000 shares in open-market buy - Stock Titan
MARPAI reports net loss of USD 3.2M in Q1 2026 - Medical Buyer
Marpai reports Q1 2026 results with cloud migration nearing completion and targets profitability in H2 2026 - Pluang
Marpai reports Q1 loss, targets second-half profitability - Investing.com
Marpai reports Q1 loss, targets second-half profitability By Investing.com - Investing.com Nigeria
Marpai (MRAI) Q1 2026 shows losses, heavy debt and going concern risk - Stock Titan
BRIEF-Marpai Q1 Revenue USD 4.4 Million - TradingView
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - PR Newswire
Finanzdaten der Marpai Inc-Aktie (MRAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.74%
0.09%
Kapitalisierung:
|
Volumen (24h):